Skip to search formSkip to main contentSkip to account menu

sevirumab

Known as: SDZ-MSL-109, protovir, SDZ MSL 109 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109
Significance The CMV glycoprotein (g) entry complex gH/gL is a significant target of the human immune system, eliciting… 
2013
2013
Einfluss verschiedener Methoden zur Bestimmung der mittleren Sprechstimmlage
ZusammenfassungHintergrundIn dieser Studie wurden unterschiedliche Methoden zur Bestimmung der mittleren Sprechstimmlage (MSL… 
2012
2012
System verification of MSL Skycrane using an integrated ADAMS simulation
Mars Science Laboratory (MSL) will use the Skycrane architecture to execute final descent and landing maneuvers. The Skycrane… 
2011
2011
Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions.
2010
2010
MINOS neutrino oscillation results
Neutrinos interact only weakly with other matter and had been thought to be massless. However, if their mass is non-zero, they… 
Highly Cited
2009
Highly Cited
2009
Marginal Space Learning for Efficient Detection of 2D/3D Anatomical Structures in Medical Images
Recently, marginal space learning (MSL) was proposed as a generic approach for automatic detection of 3D anatomical structures in… 
2004
2004
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone…
2002
2002
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial
ObjectiveTo determine the association of cytomegalovirus (CMV) viremia with mortality and CMV retinitis progression in newly… 
Review
2000
Review
2000
Therapeutic developments in cytomegalovirus retinitis
The incidence of cytomegalovirus (CMV) retinitis in AIDS has declined significantly due to the use of highly active… 
1997
1997
MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial. The Studies of Ocular…
OBJECTIVE To evaluate the efficacy and safety of an intravenous human monoclonal antibody to cytomegalovirus (CMV), MSL-109, as… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)